Advertisement

Drugs

, Volume 35, Issue 5, pp 584–595 | Cite as

Breast Cancer

Advances in Management
  • Graeme N. Brodie
  • Andrew Elefanty
Practical Therapeutics

Keywords

Breast Cancer Tamoxifen England Journal Advanced Breast Cancer Early Breast Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beadle GT, et al. Cosmetic results following primary radiation therapy for early breast cancer. Cancer 54: 2911, 1984PubMedCrossRefGoogle Scholar
  2. Bonadonna G, Valagussa P. Dose response effect of adjuvant chemotherapy in breast cancer. New England Journal of Medicine 304(1): 10–15, 1981PubMedCrossRefGoogle Scholar
  3. Bonadonna G, Valagussa P. Current status of adjuvant chemotherapy for breast cancer. Seminars in Oncology 14(1): 8, 1986Google Scholar
  4. Bonadonna G, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. New England Journal of Medicine 294: 405, 1976PubMedCrossRefGoogle Scholar
  5. Bonadonna G, et al. Adjuvant chemotherapy in breast cancer. Lancet 1: 1157, 1983PubMedCrossRefGoogle Scholar
  6. Clark GM, et al. Progesterone receptors as a prognostic factor in stage II breast cancer. New England Journal of Medicine 309: 1343, 1983PubMedCrossRefGoogle Scholar
  7. Consensus Conference. Adjuvant chemotherapy for breast cancer. Journal of the American Medical Association 254: 3461, 1985Google Scholar
  8. Danoff B, Goodman RL. Identification of a subgroup of patients with breast cancer in whom conservative surgery and radiation is contraindicated. Abstract. International Journal of Radiation: Oncology — Biology — Physics II(Suppl. 1): 104, 1985Google Scholar
  9. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. New England Journal of Medicine 312: 137, 1985CrossRefGoogle Scholar
  10. Editorial. Treatment of cancer: review of mortality results in randomised trial in early breast cancer. Lancet 2: 1205, 1984Google Scholar
  11. Findlay P, et al. A randomised trial comparing mastectomy to radiotherapy in the treatment of stage I-II breast cancer: a preliminary report. Proceedings of the American Society of Clinical Oncology 4: C–230, 1985Google Scholar
  12. Fisher B, Wolmark N. Conservative surgery: the American experience. Seminars in Oncology 13: 425, 1986PubMedGoogle Scholar
  13. Fisher B, et al. L-phenylalanine mustard (L-PAM) in the management of primary breast cancer: a report of early findings. New England Journal of Medicine 292: 117, 1975PubMedCrossRefGoogle Scholar
  14. Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4) VI. Discriminants for 5 year treatment failure. Cancer 46: 908, 1980PubMedCrossRefGoogle Scholar
  15. Fisher B, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 52: 1551, 1983PubMedCrossRefGoogle Scholar
  16. Fisher B, et al. Five year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. New England Journal of Medicine 312: 665, 1985PubMedCrossRefGoogle Scholar
  17. Fisher B, et al. Prolonging tamoxifen therapy for primary breast cancer. Annals of Internal Medicine 106: 649, 1987PubMedGoogle Scholar
  18. Haller DG, Glick JH. Progestational agents in advanced breast cancer: an overview. Seminars in Oncology 13(4): 2, 1986PubMedGoogle Scholar
  19. Harris JR, et al. Cancer of the breast. In DeVita VT, et al. (Eds) Cancer, principles and practice of oncology, 2nd ed. p. 1119–1177, JB Lippincott, Philadelphia, 1985Google Scholar
  20. Henderson IC, et al. New agents and new medical treatments for advanced breast cancer. Seminars in Oncology 14(1): 34, 1987PubMedGoogle Scholar
  21. Kennedy BJ. Hormonal therapies in breast cancer. Seminars in Oncology 1: 119, 1974PubMedGoogle Scholar
  22. Kiang DT, Kennedy BJ. Factors affecting oestrogen receptors in breast cancer. Cancer 40: 1571, 1977PubMedCrossRefGoogle Scholar
  23. Land CE. Low dose irradiation — a cause of breast cancer? Cancer 46: 868, 1980PubMedCrossRefGoogle Scholar
  24. Leathem AJ, Brooks SA. Predictive value of lectin binding on breast cancer recurrence and survival. Lancet 1: 1054, 1987PubMedCrossRefGoogle Scholar
  25. Ludwig Breast Cancer Study Group. Randomized trial of chemoendocrine therapy, endocrine therapy and mastectomy alone in post menopausal patients with operable breast cancer and axillary node metastasis. Lancet 1: 1256, 1984Google Scholar
  26. Mant D, et al. Breast self examination and breast cancer stage at diagnosis. British Journal of Cancer 55: 207, 1987PubMedCrossRefGoogle Scholar
  27. McDivitt RW, et al. A proposed classification of breast cancer based on kinetic information. Cancer 57: 269, 1986PubMedCrossRefGoogle Scholar
  28. Miller AB, Bulbrook RD. The epidemiology and etiology of breast cancer. New England Journal of Medicine 303: 1246, 1980PubMedCrossRefGoogle Scholar
  29. Musey VC, et al. Long-term effect of a first pregnancy on the secretion of prolactin. New England Journal of Medicine 316: 229, 1987PubMedCrossRefGoogle Scholar
  30. Nolvadex Adjuvant Trial Organization. Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Lancet 1: 836, 1985Google Scholar
  31. O’Connell DL, et al. Cigarette smoking, alcohol consumption, and breast cancer risk. Journal of the National Cancer Institute 72(2): 229, 1987Google Scholar
  32. Ottman R, et al. Practical guide for estimating risk for familial breast cancer. Lancet 2: 556, 1983PubMedCrossRefGoogle Scholar
  33. Plotkin D, et al. Tamoxifen flare in advanced breast cancer. Journal of the American Medical Association 240: 2644, 1978PubMedCrossRefGoogle Scholar
  34. Recht A, et al. Conservative surgery and radiation therapy for early breast cancer: results, controversies and unsolved problems. Seminars in Oncology 13(4): 434, 1986PubMedGoogle Scholar
  35. Rosner D, et al. A randomised study of intensive versus moderate chemotherapy programs in metastatic breast cancer. Cancer 59: 874, 1987PubMedCrossRefGoogle Scholar
  36. Sarrazin D, et al. Conservative treatment versus mastectomy in breast cancer tumours with macroscopic diameter of 20 millimeters or less: the experience of the Institut Gustav Roussy. Cancer 53: 1209, 1984PubMedCrossRefGoogle Scholar
  37. Sattin RW, et al. Oral-contraceptive use and the risk of breast cancer: the cancer and steroid hormone study of the Centers for Disease control and the National Institute of Child Health and Human Development. New England Journal of Medicine 315: 405, 1986CrossRefGoogle Scholar
  38. Schatzkin A, et al. Alcohol consumption and breast cancer in the epidemiologic follow-up study of the First National Health and Nutrition Examination Survey. New England Journal of Medicine 316: 1169, 1987PubMedCrossRefGoogle Scholar
  39. Shapiro S, et al. Ten to fourteen year effects of breast cancer screening on mortality. Journal of the National Cancer Institute 69: 349, 1982PubMedGoogle Scholar
  40. Stuart-Harris R, et al. Low-dose aminoglutethimide in treatment of advanced breast cancer. Lancet 2: 604, 1984PubMedCrossRefGoogle Scholar
  41. Sutherland DCM, Mather FJ. Long term survival and prognostic factors in patients with regional breast cancer. Cancer 55: 1389, 1985PubMedCrossRefGoogle Scholar
  42. Tabar L, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1: 829, 1985PubMedCrossRefGoogle Scholar
  43. Tormey DC. Long term adjuvant therapy with tamoxifen in breast cancer: how long is long? Annals of Internal Medicine 106: 762, 1987PubMedGoogle Scholar
  44. Valagussa P, et al. T3b-T4 breast cancers: factors affecting results in combined modality treatments. Clinical Experimental Metastasis I: 191, 1983CrossRefGoogle Scholar
  45. Van Heerden JA, et al. Surgical technique and pitfalls of breast reconstruction immediately after mastectomy for carcinoma: initial experience. Mayo Clinic Proceedings 62: 185, 1987PubMedGoogle Scholar
  46. Veronesi U, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. New England Journal of Medicine 305: 6, 1981PubMedCrossRefGoogle Scholar
  47. Willett WC, et al. Dietary fat and the risk of breast cancer. New England Journal of Medicine 316: 22, 1987aPubMedCrossRefGoogle Scholar
  48. Willett WC, et al. Moderate alcohol consumption and the risk of breast cancer. New England Journal of Medicine 316: 1174, 1987bPubMedCrossRefGoogle Scholar

Copyright information

© ADIS Press Limited 1988

Authors and Affiliations

  • Graeme N. Brodie
    • 1
  • Andrew Elefanty
    • 1
  1. 1.Department of Medical OncologyPrince Henry’s HospitalMelbourneAustralia

Personalised recommendations